Johns Hopkins opens proton center at Sibley Memorial Hospital

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Johns Hopkins Medicine collaborated with Children’s National Hospital to open the Johns Hopkins National Proton Center at Sibley Memorial Hospital, providing proton technology for pediatric and adult cancer patients in the District of Columbia.

The proton center is part of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore. Sibley houses the only proton center in the greater Washington, D.C. region with a dedicated pediatric team.

The proton collaboration with Children’s National Hospital represents an expansion of the earlier collaboration between Children’s and Johns Hopkins Medicine that established the pediatric radiation oncology program at Sibley, which treats a broad range of children’s cancers.

“We will be conducting groundbreaking research that will potentially help expand this technology for use in treating other types of cancers while at the same time helping improve the effectiveness of the proton treatments for the cancers currently most amenable to proton therapy,” Hasan Zia, interim president and CEO of Sibley Memorial Hospital, said in a statement.

The Johns Hopkins National Proton Center at Sibley will have a fully integrated research room, which will allow clinical, basic science, and medical physics faculty to advance clinical trial research, translational research, and technology development research in proton therapy. There, experts will lead efforts to study proton outcomes for sarcoma, gynecological tumors, pancreatic and liver tumors, lymph node cancers and tumors located near the heart and major blood vessels. In addition, the researchers will examine how the cancer cell-killing proton energy interacts with the cells and tissue surrounding the tumors.

Christina Tsien was appointed proton center medical director and Curtiland Deville will serve as the associate proton director, while maintaining his role as the clinical director for the Radiation Oncology Clinic at Sibley Memorial Hospital.

Through a strategic partnership with Howard University, the proton center will serve as an educational and training site for students enrolled in Howard’s medical physics program.

The first treatment room opened in October. The second room is scheduled to open in spring 2020, and the third room and fixed beam research room are scheduled to open in fall 2020.

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 
In 2026, more than 900 million people are estimated to be regularly using generative artificial intelligence—computer systems capable of creating human-like text, images, audio, video, and other original content. AI is becoming integrated into nearly every aspect of daily life. Health care is no exception. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login